IMA-026 represents a highly specialized humanized monoclonal antibody specifically engineered to target the human interleukin-13 cytokine with exceptional binding affinity and selectivity, effectively facilitating the measurable blockade of ligand interaction with both the IL-13R alpha 1 and IL-13R alpha 2 subunits across various preclinical experimental models to evaluate the modulation of Th2-driven inflammatory responses during strictly monitored laboratory observation periods.
CAS Nummer:
[1038541-65-9]
Target-Kategorie:
IL Receptor
T9901A-1292
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
